Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADVFN Regulatory News (AFN)

  • There is currently no data for AFN

Director/PDMR Shareholding

23 Mar 2023 15:30

RNS Number : 0622U
ADVFN PLC
23 March 2023
 

For immediate release

23 March 2023

ADVFN plc

("ADVFN" or the ''Company'')

Director / PDMR shareholding

Admission became effective and dealings commenced on 22 March 2023 in the new ordinary shares issued pursuant to the Open Offer.

As previously announced, 1,057,576 Open Offer Shares were issued to Amit Tauman, a director of the Company together with 352,525 Open Offer Warrants (as set out in the Appendix). Following admission, Amit Tauman is interested in aggregate 5,437,972 Ordinary Shares representing 11.82 per cent. of the ordinary issued share capital.

A copy of this announcement is available on the Company's website, www.advfnplc.com.

For further information please contact:

ADVFN plc

Amit Tauman (CEO)

+44 (0) 203 8794 460

Beaumont Cornish Limited (Nominated Adviser)

Michael Cornish

Roland Cornish

+44 (0) 207 628 3396

Peterhouse Capital Limited (Broker)

Eran Zucker / Lucy Williams / Rose Greensmith

+44 (0) 207 469 0930

 

Appendix

The notification below, made in accordance with the requirements of the EU Market Abuse Regulations, provides further detail in respect of the transaction as described above.

 

 

1

Details  of  the  person  discharging  managerial  responsibilities  /  person  closely associated

 

a)

Name

Amit Tauman

2

Reason for notification

 

a)

Position / status

Chief Executive

 

b)

Initial notification

/Amendment

 

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

ADVFN plc

 

b)

LEI

21380042SDV1E1ZVIY40

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description  of the financial instrument, type of instrument

Identification code

Ordinary shares of 0.2 pence each in ADVFN plc

 

ISIN GB00BPT24C10

 

Warrant over ordinary shares

ISIN GB00BPSMFX03

Nature of the transaction

Issued pursuant to participation in an Open Offer

 

Price(s) and volumes(s)

 

 

 

 

 

Price(s)

Volumes(s)

£0.33

 

1,057,576 new Ordinary Shares

£0.00

 

352,525 Open Offer Warrants

d)

Aggregated information

n/a

 

e)

Date of the transaction

22 March 2023

 

f)

Place of the transaction

AIMX

 

ENDS

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEXLFLXXLLBBX
Date   Source Headline
22nd Nov 20217:00 amRNSHolding(s) in Company
17th Nov 20217:00 amRNSNominations Open for ADVFN Financial Awards 2022
10th Nov 20218:00 amRNSADVFN Capital Markets Event
10th Nov 20217:00 amRNSFinal Results
12th Oct 20217:00 amRNSWins Cryptocurrency Platform Provider of the Year
14th Sep 20217:00 amRNSSmart Investing Webinars for Robinhood Generation
27th Aug 20211:11 pmRNSInvestor Webinar to Update on Recent Developments
15th Jul 20217:00 amRNSCEO to answer questions at prime investor event
5th Jul 202112:00 pmRNSTrading update and proposed dividend policy
28th May 202111:05 amRNSSecond Price Monitoring Extn
28th May 202111:00 amRNSPrice Monitoring Extension
28th May 20219:05 amRNSSecond Price Monitoring Extn
28th May 20219:00 amRNSPrice Monitoring Extension
27th May 20214:40 pmRNSSecond Price Monitoring Extn
27th May 20214:35 pmRNSPrice Monitoring Extension
27th May 20212:05 pmRNSSecond Price Monitoring Extn
27th May 20212:00 pmRNSPrice Monitoring Extension
10th May 20217:00 amRNSCorporate update
4th May 202111:49 amRNSHolding(s) in Company
4th May 202111:47 amRNSHolding(s) in Company
30th Apr 20217:00 amRNSDirector/PDMR Shareholding
29th Apr 20219:20 amRNSHolding(s) in Company
23rd Mar 20217:00 amRNSADVFN International Financial Awards 2021: Winners
18th Feb 20217:00 amRNSHalf-year Report
14th Jan 20214:40 pmRNSSecond Price Monitoring Extn
14th Jan 20214:35 pmRNSPrice Monitoring Extension
12th Jan 20214:25 pmRNSHolding(s) in Company
8th Jan 20214:35 pmRNSPrice Monitoring Extension
30th Dec 202012:38 pmRNSDirector/PDMR Shareholding
21st Dec 20205:30 pmRNSResult of AGM
12th Nov 20207:00 amRNSNominations open for ADVFN Financial Awards 2021
4th Nov 20207:00 amRNSADVFN and Edison partner for global IR solutions
26th Oct 20207:00 amRNSFinal Results
19th Oct 20207:00 amRNSDirectorate Change
25th Mar 20204:20 pmRNSHalf-year Report
18th Mar 20207:00 amRNSADVFN International Financial Awards 2020: winners
10th Mar 20209:00 amRNSPrice Monitoring Extension
9th Mar 20204:40 pmRNSSecond Price Monitoring Extn
9th Mar 20204:36 pmRNSPrice Monitoring Extension
9th Mar 20202:06 pmRNSSecond Price Monitoring Extn
9th Mar 20202:00 pmRNSPrice Monitoring Extension
9th Mar 202011:05 amRNSSecond Price Monitoring Extn
9th Mar 202011:00 amRNSPrice Monitoring Extension
6th Mar 20204:40 pmRNSSecond Price Monitoring Extn
6th Mar 20204:35 pmRNSPrice Monitoring Extension
6th Mar 20202:05 pmRNSSecond Price Monitoring Extn
6th Mar 20202:00 pmRNSPrice Monitoring Extension
25th Feb 20207:00 amRNSAddition of Aquis Exchange Data to ADVFN Level 2
21st Jan 20207:30 amRNSTrading Update
20th Jan 20207:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.